+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infertility Treatment - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 505 Pages
  • July 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805789

Global Infertility Treatment Market to Reach $2.1 Billion by 2026


Infertility treatment worldwide will continue to be led by postponement of childbearing. Growth will also be driven by rising private-public investments as well as grants and funds, decreasing global fertility rate, rising acceptance and awareness of infertility diagnosis and treatment globally, and technological advancements in reproductive technologies. In addition, factors that include alcohol consumption, increasing use of tobacco higher obesity rate and higher marital age are also stimulating the assisted reproductive market growth. Among the key infertility treatment procedures, assisted reproductive technology (ART) based procedures is witnessing faster growth, and with the introduction of aseptic vitrification, which is a new cell cryopreservation technique, ART procedures will gain further share for infertility treatment. Incidence of endometriosis, polycystic ovarian syndrome (PCOS) and tubal factors have and will continue to propel growth of assisted reproductive treatment (ART). Currently, the IVF procedure is fairly successful and is increasingly accepted as a highly potential treatment method for infertility. Awareness about different infertility treatment procedures, increasing female infertility rate, and rising number of fertility centers will contribute the growth of female infertility treatment.

Amid the COVID-19 crisis, the global market for Infertility Treatment estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$2.1 Billion by 2026, growing at a CAGR of 6.7% over the analysis period. Equipment, one of the segments analyzed in the report, is projected to grow at a 6.6% CAGR to reach US$1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Media & Consumables segment is readjusted to a revised 7.2% CAGR for the next 7-year period. This segment currently accounts for a 36.4% share of the global Infertility Treatment market.

The U.S. Market is Estimated at $359 Million in 2022, While China is Forecast to Reach $462.7 Million by 2026


The Infertility Treatment market in the U.S. is estimated at US$359 Million in the year 2022. The country currently accounts for a 22.64% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$462.7 Million in the year 2026 trailing a CAGR of 8.1% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6% CAGR while Rest of European market (as defined in the study) will reach US$502.2 Million by the end of the analysis period. Developing countries are augmenting research in the areas of infertility, as the infertility burden is highest in developing regions. Infertility research in developing regions requires focusing on cost-effective, safe and innovative solutions and improving the integration and accessibility to infertility/sub-fertility diagnosis, treatment and management. Growth in the Asia-Pacific region is attributable to superior healthcare infrastructure, increasing acceptance of IVF procedures and growing awareness. The increasing programs and initiatives for improving awareness on infertility and advanced treatments in emerging nations, for example South Africa and India is expected to further drive market growth.

Accessories Segment to Reach $387.9 Million by 2026


In the global Accessories segment, USA, Canada, Japan, China and Europe will drive the 5.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$220.3 Million will reach a projected size of US$323.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$47.5 Million by the year 2026, while Latin America will expand at a 6.2% CAGR through the analysis period.

Select Competitors (Total 67 Featured):

  • Cook Group Incorporated
  • CooperSurgical Fertility & Genomic Solutions
  • Esco Micro Pte. Ltd
  • Ferring B.V.
  • FUJIFILM Irvine Scientific
  • Genea Limited
  • Hamilton Thorne, Inc
  • Ihmedical A/S
  • INVO Bioscience
  • IVFTech Aps
  • Kitazato Corporation
  • LABOTECT GMBH
  • Medgyn Products, Inc
  • Merck KGaA
  • Rocket Medical PLC
  • Somatex Medical Technologies GmbH
  • Thermo Fisher Scientific
  • Vitrolife AB
  • ZEISS International

What`s New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the digital archives
  • Complimentary updates for one year
The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Infertility Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Infertility Emerges Into a Global Health Issue
  • How Are Total Fertility Rates Calculated & What They Really mean?
  • Indications that Fertility Levels Are Continuing to Dip
  • Age, a Key Determinant of Fertility
  • COVID-19 Pandemic Disrupts Routine Healthcare, Elicits US$89.5 Million Losses in Infertility Treatment Revenues
  • How the COVID-19 Pandemic Destroyed the Global Economy
  • COVID-19 Leaves the World in Shambles & Industries and Markets Upended: World Economic Growth Projections (Real GDP, Annual % Change) for 2019, 2020 & 2021
  • Amid This Public Health Crisis of Unimagined Magnitude, Non-COVID-19 Healthcare Faces the Brunt of Disruptions
  • COVID-19 Impact on Healthcare Can be See in the Decline in Number of Non-Essential Surgeries: Annual General Surgeries Performed Worldwide (In Million)
  • Rise in Unemployment Amidst Economic Fallout from Covid-19 Push Couples to Consider Delaying Parenthood Plans
  • Rising Levels of Unemployment Delays Planned Parenthood Decisions Among Infertile Couples: Unemployment in the U.S. (In Million)
  • Infertility Treatment: Definition, Scope & Types
  • Special Focus On Assisted Reproductive Technology (ART) & IVF
  • IVF, the Most Popular Form of ART
  • New Alternative Treatment Techniques for IVF Begin to Emerge
  • Other Popular Treatment Types
  • Intrauterine Insemination (IUI)
  • IntraCytoplasmic Sperm Injection (ICSI)
  • Others
  • Recent Market Activity
  • Innovations
  • World Brands
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Global Market Outlook 2020 & Beyond
  • A Peek Into Regional Dynamics
  • An Analysis of Growth Prospects in the Artificial Insemination Market
  • Infertility Treatment Options Expands to Include Surrogate Motherhood
  • Surrogacy: Types, Process & Cost
  • Surrogacy Fertility Tourism
  • Ethical & Legal Dilemmas
  • Mushrooming of Fertility Clinics to Benefit Market Growth
  • Private Investments in Fertility Clinic Chains Increases
  • Infertility Clinics Adopt Automation Technologies to Enhance Effectiveness of In-Vitro Fertilization Procedures
  • With Obesity Impairing Fertility, Rising Obesity Rates Are Pushing UP Demand for Fertility Treatment
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Endometriosis is One of the Most Common Causes of Infertility
  • Supported by Myriad Factors, IVF Witnesses the Highest Growth
  • Technology Innovation, Research & Equipment Automation Gain Momentum
  • Fertility Medical Tourism Continues to Rise Amid Controversies
  • Spain, the Preferred Country for Fertility Tourism
  • Changing Laws Bring Other Countries Into the Spotlight
  • Male Infertility, A Traditionally Under Researched Area Gains Attention
  • TEX101 as Potential Biomarker of Male Infertility
  • Home Based Semen Analysis Gains in Prominence
  • Global Innovations in Fertility Treatments Crucial for Continued Growth of the Market
  • Novel Techniques of Sperm Selection
  • Advancements in Chromosome Testing
  • Innovations in Treating T-Shaped Uterus, a Uterine Malformation Responsible for Infertility
  • Fertility No Longer Needs to be Limited by Age. The Promise of Prolonged Fertility is Here
  • Embryo Analysis
  • New Drugs in Development
  • Digital Technologies Like Artificial Intelligence Come to the Aid for Improving Success Rates
4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS
UNITED STATES
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
CANADA
JAPAN
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Market Overview
CHINA
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Market Overview
EUROPE
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
FRANCE
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Market Overview
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
AUSTRALIA
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
  • Market Overview
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
  • Market Overview
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Infertility Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION
  • Total Companies Profiled: 67

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cook Group Incorporated
  • CooperSurgical Fertility & Genomic Solutions
  • Esco Micro Pte. Ltd
  • Ferring B.V.
  • FUJIFILM Irvine Scientific
  • Genea Limited
  • Hamilton Thorne, Inc
  • Ihmedical A/S
  • INVO Bioscience
  • IVFTech Aps
  • Kitazato Corporation
  • LABOTECT GMBH
  • Medgyn Products, Inc
  • Merck KGaA
  • Rocket Medical PLC
  • Somatex Medical Technologies GmbH
  • Thermo Fisher Scientific
  • Vitrolife AB
  • ZEISS International